Blood clotting and drug effects (Homo sapiens)
From WikiPathways
Description
Formation of a blood clot by arachidonic acid. This pathway also shows various stimulants/inhibitors that have an effect on the pathway, while also showing the two compounds which respectively cause vasoconstriction/vasodilation and inhibit/stimulate platelet aggregation.
Quality Tags
Ontology Terms
Bibliography
- Glen D. Lawrence; ''The Fats of Life: Essential Fatty Acids in Health and Disease''; 978-0-8135-4677-3, 2010
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
Arachidonic acid | Metabolite | CHEBI:15843 (ChEBI) | |
COX | Protein | IPR038147 (InterPro) | |
Coumadin | Metabolite | CHEBI:10034 (ChEBI) | |
Cross-linked fibrin | Pathway | WP4927 (WikiPathways) | |
Eicosanoid synthesis | Pathway | WP167 (WikiPathways) | |
Fibrin | Metabolite | CHEBI:5054 (ChEBI) | |
Fibrinogen | Protein | Q381899 (Wikidata) | |
NSAIDs | Metabolite | CHEBI:35475 (ChEBI) | |
Prostacyclin | Metabolite | CHEBI:15552 (ChEBI) | |
Prostaglandin H2 | Metabolite | CHEBI:15554 (ChEBI) | |
Prothrombin | Metabolite | CHEBI:8583 (ChEBI) | |
Thrombin | Metabolite | CHEBI:9574 (ChEBI) | |
Thromboxane A2 | Metabolite | CHEBI:15627 (ChEBI) | |
Vitamin K pathway | Pathway | WP5186 (WikiPathways) | |
Vitamin K | Metabolite | CHEBI:28384 (ChEBI) |
Annotated Interactions
No annotated interactions